Cone Beam CT Scanning in Lung and Bladder Cancer.

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Alberta Health Services

ClinicalTrials.gov Identifier:

NCT00469066

First received: May 2, 2007

Last updated: December 8, 2011

Last verified: December 2011

History of Changes

Tracking Information

First Received Date ^ICMJE

May 2, 2007

Last Updated Date

December 8, 2011

Start Date ^ICMJE

May 2007

Primary Completion Date

August 2009 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

Not Provided

Original Primary Outcome Measures ^ICMJE

Not Provided

Change History

Complete list of historical versions of study NCT00469066 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Cone Beam CT Scanning in Lung and Bladder Cancer.

Official Title ^ICMJE

Improving the Accuracy of Radiotherapy Planning and Delivery Using Kilovoltage Cone Beam CT Imaging

Brief Summary

To study changes in tumor and normal organ size and/or position which occur during a course of radiation treatments.

Detailed Description

Not Provided

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Observational Model: Case-Only
Time Perspective: Prospective

Target Follow-Up Duration

Not Provided

Biospecimen

Not Provided

Sampling Method

Non-Probability Sample

Study Population

primary care clniic

Condition ^ICMJE

Lung Neoplasm
Small Cell Carcinoma
Bladder Carcinoma

Intervention ^ICMJE

Not Provided

Study Group/Cohort (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Completion Date

April 2010

Primary Completion Date

August 2009 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Patient has biopsy proven limited stage SCLC
receiving radical concurrent chemoradiotherapy
no prior chest RT
no prior surgical resection of lung tumor
no prior chemotherapy
patients' lung tumors should be centrally-located to minimize the effect of respiratory motion
patient has biopsy proven TCC bladder
receiving radical concurrent chemoradiotherapy or RT alone
no prior chemotherapy
patient signs study-specific consent form

Exclusion Criteria:

mixed small cell and non small cell histology
patient not being treated with concurrent chemoradiotherapy
chemoradiotherapy given sequentially
previous chest RT
previous chemotherapy
prior surgical resection of lung mass
patient ineligible for pelvic RT
patient does not sign study consent

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

Canada

Administrative Information

NCT Number ^ICMJE

NCT00469066

Other Study ID Numbers ^ICMJE

LU-11-0073

Has Data Monitoring Committee

Yes

Responsible Party

Alberta Health Services

Study Sponsor ^ICMJE

Alberta Health Services

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Principal Investigator:

Don Yee, MD

Alberta Health Services

Information Provided By

Alberta Health Services

Verification Date

December 2011

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top